Exploring the Determinants of Long COVID in Sub-Saharan Africa: A Scoping Review - Scorecard - MDSpire

Exploring the Determinants of Long COVID in Sub-Saharan Africa: A Scoping Review

  • By

  • Valdez Jaures Njio Heugno

  • Odette Linda Kamdem

  • Estelle Geraldine Essangui Same

  • Elysée Claude Bika Lele

  • Yves Mbama Biloa

  • Clarisse Ayina Ayina

  • Jessica Guyot

  • Bienvenu Bongue

  • Samuel Honore Mandengue

  • Carole Else Eboumbou Moukoko

  • March 4, 2026

  • 0 min

Share

Clinical Scorecard: Exploring the Determinants of Long COVID in Sub-Saharan Africa: A Scoping Review

At a Glance

CategoryDetail
ConditionLong COVID (Post-COVID-19 syndrome, PASC)
Key MechanismsPersistence or new onset of symptoms beyond acute SARS-CoV-2 infection, affecting multiple organ systems
Target PopulationIndividuals in sub-Saharan Africa with prior probable or confirmed SARS-CoV-2 infection
Care SettingPrimary and specialized healthcare settings with limited diagnostic and follow-up resources

Key Highlights

  • Long COVID affects 10-30% of COVID-19 patients globally, with emerging evidence of significant burden in sub-Saharan Africa despite limited data.
  • Definitions of long COVID vary internationally, complicating diagnosis and comparison; WHO defines it as symptoms persisting ≥3 months post-infection.
  • Sub-Saharan Africa faces unique challenges including youthful population, high prevalence of infectious and non-communicable comorbidities, limited healthcare resources, and socio-economic factors impacting diagnosis and management.

Guideline-Based Recommendations

Diagnosis

  • Use WHO criteria: symptoms persisting at least 2 months, starting usually 3 months after COVID-19 onset, unexplained by other diagnoses.
  • Recognize heterogeneity of symptoms affecting multiple organ systems including fatigue, respiratory, cognitive, neuropsychiatric, and gastrointestinal manifestations.
  • Adapt diagnostic criteria to local resource constraints and consider probable cases where confirmatory testing is limited.

Management

  • Implement context-appropriate post-COVID rehabilitation programs, noting that less than 30% of sub-Saharan countries currently have such programs.
  • Address comorbidities such as HIV/AIDS, tuberculosis, malaria, hypertension, and diabetes in management plans.
  • Incorporate traditional medicine practices where culturally relevant, ensuring integration with biomedical care.

Monitoring & Follow-up

  • Establish epidemiological surveillance systems for long COVID despite resource limitations.
  • Train healthcare personnel in recognition and management of post-COVID sequelae.
  • Coordinate care across fragmented health systems to improve follow-up and patient outcomes.

Risks

  • High risk of under-diagnosis due to limited access to testing and healthcare.
  • Socioeconomic factors such as poverty, overcrowding, and informal employment hinder isolation and care adherence.
  • Comorbid infectious and non-communicable diseases may increase susceptibility and complicate clinical course.

Patient & Prescribing Data

Individuals in sub-Saharan Africa with prior SARS-CoV-2 infection experiencing persistent symptoms

Limited data on pharmacological treatments; emphasis on supportive care, rehabilitation, and management of comorbidities tailored to resource availability

Clinical Best Practices

  • Harmonize diagnostic criteria regionally to improve case identification and comparability.
  • Develop and expand post-COVID rehabilitation services adapted to local healthcare capacities.
  • Integrate multidisciplinary approaches including mental health support and management of chronic diseases.
  • Enhance training of healthcare workers on long COVID recognition and management.
  • Promote community engagement and culturally sensitive communication to improve health-seeking behavior.

References

Original Source(s)

Related Content